SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-099113
Filing Date
2024-04-17
Accepted
2024-04-17 16:16:56
Documents
6
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d788777ddef14a.htm DEF 14A 390665
2 GRAPHIC g788777g00a02.jpg GRAPHIC 31553
3 GRAPHIC g788777g16g16.jpg GRAPHIC 167865
4 GRAPHIC g788777g17g17.jpg GRAPHIC 192251
5 GRAPHIC g788777g55n05.jpg GRAPHIC 37979
6 GRAPHIC g788777g62x94.jpg GRAPHIC 32880
  Complete submission text file 0001193125-24-099113.txt   1025885
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39122 | Film No.: 24851279
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)